The role of peripheral T-cell deletion in transplantation tolerance

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 356, Issue 1409, 2001, Pages 617-623

  Wells, A D ^a   Li, X C ^a   Strom, T B ^a   Turka, L A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Apoptosis; Interleukin 2; Peripheral deletion; T lymphocyte; Tolerance

Indexed keywords

EID: 0035967487     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.2001.0845     Document Type: Review

References (63)

1. Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts
2. Protein phosphatase lalpha is a Ras-activated Bad phosphatase that regulates interleukin-2 deprivation-induced apoptosis
3. + T cells in transgenic mice expressing H-2Kb in the liver
4. Reversal of in vitro T cell clonal anergy by IL-2 stimulation
5. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin
6. CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis
7. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL
8. Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells
9. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity
10. The UNOS scientific renal transplant registry
11. Rapamycin-induced long-term allograft survival depends on persistence of alloantigen
12. Regulation of the pro-inflammatory effects of Fas ligand (CD95L)
13. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice
14. Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis
15. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin
16. Natural adjuvants: Endogenous activators of dendritic cells
17. Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis
18. Fas ligand-induced apoptosis as a mechanism of immune privilege
19. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance
20. Bcl-XL displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice
21. Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: Effector function is linked to proliferative capacity
22. Reactive oxygen species regulate activation-induced T cell apoptosis
23. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L)
24. Role of passive T-cell death in chronic experimental autoimmune encephalomyelitis
25. Signals and signs for lymphocyte responses
26. Peripheral clonal elimination of functional T cells
27. Apoptosis, graft rejection, and transplantation tolerance
28. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction
29. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B
30. A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism
31. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
32. Immune responses in interleukin-2-deficient mice
33. + T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity
34. + T cells
35. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
36. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice
37. On histocompatibility barriers, Th1 to Th2 immune deviation, and the nature of the allograft responses
38. Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment
39. Induction of allograft tolerance in the absence of Fas-mediated apoptosis
40. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance
41. T-lymphocyte downregulation after acute viral infection is not dependent on CD95 (Fas) receptor-ligand interactions
42. Extinction of IL-12 signaling promotes Fas-mediated apoptosis of antigen-specific T cells
43. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival
44. Interleukin-2-mediated elimination of the p27Kipl cyclin-dependent kinase inhibitor prevented by rapamycin
45. + T cells persist in vivo following induction of peripheral tolerance
46. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase
47. The central effectors of cell death in the immune system
48. Immune down-regulation and peripheral deletion of CD8 T cells does not require TNF receptor-ligand interactions nor CD95 (Fas, APO-1)
49. The role of T-cell costimulatory activation pathways in transplant rejection
50. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2
51. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting
52. IL-2 knockout recipient mice reject islet cell allografts
53. The induction of tolerance by dendritic cells that have captured apoptotic cells
54. Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments
55. The interleukin-2 receptor gamma chain: Its role in the multiple cytokine receptor complexes and T cell development in XSCID
56. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment
57. Homeostasis and self-tolerance in the immune system: Turning lymphocytes off
58. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance
59. Transplantation tolerance - Where do we stand?
60. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance
61. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment
62. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance
63. Induction of apoptosis in mature T cells by tumour necrosis factor